Stock ownership · SEC 13F · Q4 2025

JAZZ PHARMACEUTICALS PLC

A breakdown of JAZZ PHARMACEUTICALS PLC's institutional base (CUSIP G50871105): the holders, the concentration among them, and what changed last quarter.

$110.7M
Reported value
4
Institutions
100%
Top-5 share

The verdict

$110.7M of JAZZ PHARMACEUTICALS PLC is reported by 4 institutions as of Q4 2025; ownership is held overwhelmingly by a small core of institutions.

4
institutions hold it
$110.7M
reported 13F value
100%
held by top 5

Based on long positions reported to the SEC as of Q4 2025; 13F omits shorts, options and non-US holdings.

How 13F ownership is computed · All tracked stocks · Concentration rankings

SEC Form 13F-HR ownership desk

CUSIP G50871105 · Q4 2025 $111M reported

VALUE-LIGHT · HOLDERS-FOCUS · CONC-DOM · PHOTO-UNK · ACTIVITY-MID · BOOK-MID

  • VALUE-LIGHT $111M
  • HOLDERS-FOCUS 4 filers
  • CONC-DOM 100% top-5
  • PHOTO-UNK No peer
  • ACTIVITY-MID 3 new
  • BOOK-MID 7Q history

Read with: Ownership concentration guide - JAZZ PHARMACEUTICALS PLC's top-five holders account for 100% of reported value — read concentration before treating any single filer as a signal.

Largest institutional holders of JAZZ PHARMACEUTICALS PLC
  1. 1
    Pacer Advisors, Inc. $110.0M
  2. 2
    GROUPAMA ASSET MANAGMENT $438K
  3. 3
    DGS Capital Management, LLC $260K
  4. 4
    Bell Investment Advisors, Inc $4K

Top 4 reported holders by value · Q4 2025

Institutional ownership over time

The number of institutions reporting a JAZZ PHARMACEUTICALS PLC position has risen from 3 to 4 over the last 7 quarters of 13F filings.

0123456 Q1'24Q3'24Q4'24Q1'25Q2'25Q3'25Q4'25 4
Distinct 13F filers holding JAZZ PHARMACEUTICALS PLC, by quarter

Top Institutional Holders

# Institution Shares Value Share of reported
1 Pacer Advisors, Inc. 647,084 $110.0M 99.4%
2 GROUPAMA ASSET MANAGMENT 2,576 $438K 0.4%
3 DGS Capital Management, LLC 1,531 $260K 0.2%
4 Bell Investment Advisors, Inc 22 $4K 0.0%

Investment Discretion

SEC Form 13F requires each institutional filer to report whether it exercises sole or shared discretion over a position. Among JAZZ PHARMACEUTICALS PLC's reported holders for Q4 2025, by reported value:

Sole discretion (SOLE)
100.0%

Latest Quarter Activity · Q4 2025

New positions (3)

Pacer Advisors, Inc. $110.0M
GROUPAMA ASSET MANAGMENT $438K
DGS Capital Management, LLC $260K

Complete exits (3)

CIBC Private Wealth Group LLC exited
Vermillion & White Wealth Management Group, LLC exited
JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) exited

Frequently Asked Questions

How many institutions hold JAZZ PHARMACEUTICALS PLC?▼
JAZZ PHARMACEUTICALS PLC is held by 4 institutional investors per the latest SEC Form 13F filings as of Q4 2025.
What is the total institutional value of JAZZ PHARMACEUTICALS PLC?▼
Institutions report $110.7M of JAZZ PHARMACEUTICALS PLC as of Q4 2025.
How concentrated is ownership of JAZZ PHARMACEUTICALS PLC?▼
The top five institutional holders account for 100% of the reported institutional value in JAZZ PHARMACEUTICALS PLC, making ownership held overwhelmingly by a small core of institutions.
Who is the largest institutional holder of JAZZ PHARMACEUTICALS PLC?▼
Pacer Advisors, Inc. is the largest reported holder of JAZZ PHARMACEUTICALS PLC with $110.0M across 647,084 shares as of Q4 2025.

Source: U.S. Securities and Exchange Commission (SEC) - EDGAR Form 13F-HR institutional holdings filings · Q4 2025 13F-HR discloses long US-listed equity positions of managers with $100M+ qualifying assets, filed within 45 days of period end. Short positions and most derivatives are not disclosed.

PlainFundData is rendered directly from SEC EDGAR Form 13F-HR institutional holdings filings, no number is typed in by an editor. Holder lists, concentration, and reported value on this page are aggregated live from those 13F-HR extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-16.